We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Events

09 Apr 2024 - 12 Apr 2024
15 Apr 2024 - 17 Apr 2024
23 Apr 2024 - 26 Apr 2024

Simple Assay Determines Lymphoma Subtypes Rapidly

By LabMedica International staff writers
Posted on 28 Apr 2015
Print article
Image: Photomicrograph of a diffuse large B cell lymphoma of a fine needle aspirate specimen from a lymph node (Photo courtesy of Nephron).
Image: Photomicrograph of a diffuse large B cell lymphoma of a fine needle aspirate specimen from a lymph node (Photo courtesy of Nephron).
Diffuse large B-cell lymphoma (DLBCL), the most common non-Hodgkin lymphoma, is subdivided into germinal center B-cell-like and activated B-cell-like subtypes, but these lymphomas are difficult to discriminate in routine diagnosis, impeding the development of treatments.

These lymphomas are germinal center B-cell-like (GCB) and activated B-cell-like (ABC), which differs in management and outcomes, and with the advent of targeted lymphoma therapies on the horizon, it becomes increasingly important to differentiate the two major subtypes.

Scientists at the University of Rouen (Mont-Saint-Aignan, France) evaluated the use of the reverse transcriptase multiplex ligation-dependent probe amplification (RT-MLPA) assay for differentiating DLBCL subtypes. RT-MLPA is as accurate as the current gold standard technology and offers advantages such as simplicity, flexibility, short turnaround time, low cost, and efficiency. They analyzed lymph node biopsies from 259 patients with de novo DLBCL, including 195 patients from the Centre Henri Becquerel (Rouen, France) and 64 from an external group.

The team developed a simple and rapid classifier based on a reverse transcriptase multiplex ligation-dependent probe amplification assay and 14 gene signatures, and compared it with the U133+2 GeneChip arrays (Affymetrix; Santa Clara, CA, USA) as the gold standard. In a training series of 50 randomly selected DLBCL cases, the new method classified 90% of the cases into the expected subtypes (20 GCB and 25 ABC), whereas 10% were considered unclassifiable. In a second independent validation series, 93% of 65 samples were classified correctly with RT-MLPA.

The investigators also showed that RT-MLPA is sensitive for analyzing archived formalin-fixed, paraffin-embedded (FFPE) tissue samples. Comparison of samples from paired frozen and FFPE biopsies showed that the RT-MLPA assay correctly classified 89.3% of 28 cases. To evaluate the prognostic value of the assay, the scientists looked at survival in 135 treated lymphoma patients diagnosed between 2001 and 2011. They found that patients determined to have the ABC subtype by the RT-MLPA assay had significantly worse progression-free survival and overall survival than those with the GCB subtype.

Philippe Ruminy, PhD, the lead investigator, said, “The robust and cost-effective RT-MLPA assay can yield results within one day and requires reagents costing less than USD 5 per sample. Since RT-MLPA utilizes materials and equipment that are standard in many laboratories, the process can easily be implemented for routine use.” The study was published in the May 2015 issue of the Journal of Molecular Diagnostics.

Related Links:
University of Rouen 
Centre Henri Becquerel
Affymetrix 


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Specimen Collection & Transport
Complement 3 (C3) Test
GPP-100 C3 Kit
New
Gold Member
Systemic Autoimmune Testing Assay
BioPlex 2200 ANA Screen with MDSS

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Molecular Diagnostics

view channel
Image: MOF materials efficiently enrich cfDNA and cfRNA in blood through simple operational process (Photo courtesy of Science China Press)

Blood Circulating Nucleic Acid Enrichment Technique Enables Non-Invasive Liver Cancer Diagnosis

The ability to diagnose diseases early can significantly enhance the effectiveness of clinical treatments and improve survival rates. One promising approach for non-invasive early diagnosis is the use... Read more

Hematology

view channel
Image: The low-cost portable device rapidly identifies chemotherapy patients at risk of sepsis (Photo courtesy of 52North Health)

POC Finger-Prick Blood Test Determines Risk of Neutropenic Sepsis in Patients Undergoing Chemotherapy

Neutropenia, a decrease in neutrophils (a type of white blood cell crucial for fighting infections), is a frequent side effect of certain cancer treatments. This condition elevates the risk of infections,... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.